Found 89 results in Expert Content

This executive summary provides expert insight on overcoming manufacturing challenges associated with expedited development programs.

Summary: In this webinar, experts provide an overview of the latest trends in manufacturing of oral solid dosage form and discuss key considerations of transitioning an early-stage project to late-stage as well as technology transfer.

Summary: A growing number of drug launches have faltered at the final hour because manufacturing processes weren’t up to FDA standards. This webinar explores how drug developers can properly monitor quality throughout the clinical production process and fix any issues that arise—before the FDA brings out the red flags.

Summary: This webinar provides an introduction and comparison of top-spray and bottom-spray fluid bed coating technologies and how to select the most appropriate technique to meet the target product profile.

Summary: In this webinar, learn from real world case studies about best practices and strategies to mitigate risks and ensure a successful tech transfer from development through to commercial scale spray drying of pharmaceutical products.

Summary: This eBook includes an overview of outsourcing trends in the oral solid dose market. Featured articles describe the robust market resulting from the demand for specialized dosage forms such as controlled release, pediatric and geriatric delivery vehicles.

Summary: OneXpress® is a single integrated solution that provides the fastest pathway from clinical to commercial manufacturing.

Summary: ​Learn more about how the transition from early to late phase of a small molecule program plays a pivotal role in a program’s ultimate success.

Summary: Catalent CEO Johh Chiminski discusses how the pandemic has made us question how the future of pharma manufacturing will be altered post Covid-19.

Summary: In this webinar, Catalent experts will explain how the phase appropriate expertise and technologies of the OneXpress® Solution can help streamline development and manufacturing, speed up your program timelines and reduce risks to transform your science into a successful treatment.